Trial Profile
Effect of a fixed dose combination of perindopril and amlodipine on patients with essential hypertension
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Perindopril/amlodipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms CONTROL
- 09 Feb 2016 New trial record
- 30 Jan 2016 Primary endpoint (The percentage of patients with controlled BP (both systolic and diastolic) at study termination (week 12)) has been met, as per the results published in the Clinical Drug Investigation.
- 30 Jan 2016 Results published in the Clinical Drug Investigation